Eventide Asset Management’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$2.37M Hold
2024
Q4
$4.45M Hold
2024
Q3
$3.13M Hold
2024
Q2
$3.13M Hold
2024
Q1
$3.13M Hold
2023
Q4
$3.25M Buy
2018
Q2
Sell
2018
Q1
$940K Buy